Palantir's NHS Contract Controversy: Privacy Concerns and Public Opposition

Multiple Sources
2020-2026

NHS England awarded US IT group Palantir a contract to create a new federated data platform (FDP) designed to bring together existing NHS data into a single framework. The contract, potentially worth "up to £330 million" over seven years, has sparked significant controversy centered on data privacy, transparency, and Peter Thiel's connection to the company.

THE CONTRACT OVERVIEW

Palantir's contract involves creating a federated data platform for the NHS that would integrate data from across the healthcare system. The contract was initially awarded as an emergency non-competitive contract during the COVID-19 pandemic and was subsequently extended.

NHS England stated that the FDP will cover real-time data and stressed that GP data will not be fed into the system. Under the contract, Palantir cannot commercialise or market NHS data, even on an anonymised basis, or use NHS data to develop new products.

KEY PRIVACY CONCERNS

Amnesty International's business and human rights director called for assurance that personal information won't be harvested for purposes unrelated to health and said the tech firm "should be required to give cast-iron guarantees that they won't monetise health data collected from the NHS."

A major threat identified is what's called "mission creep," where Palantir could eventually request access to more data. Additionally, a YouGov poll suggested that 48% of UK adults who have not yet opted out are likely to do so if the FDP is run by a private company.

TRANSPARENCY ISSUES

When Palantir's contract was published by NHS England, 417 out of 586 pages were completely blanked out. The Good Law Project filed legal action to force NHS England to disclose the missing sections, achieving a partial victory in the fight for transparency.

CONCERNS ABOUT PALANTIR'S BACKGROUND

Media attention has focused on Palantir being chaired by Donald Trump ally and PayPal co-founder Peter Thiel, who has said publicly he believes the NHS should be privatised. The company has been linked to controversial practices such as predictive policing and the targeting of migrant populations.

PUBLIC OPPOSITION

The contract has faced backlash over reputation concerns and public opposition. NHS Palantir contract faces scrutiny from medical professionals, privacy advocates, and members of parliament.

Green Party's Zack Polanski stated: "Defence surveillance corporation Palantir should pack its bags and get the hell out of the NHS."

HOSPITAL ADOPTION RESISTANCE

Palantir's NHS data platform has been rejected by most hospitals, according to reporting. Many NHS trusts have expressed reluctance to fully adopt the system due to privacy concerns and distrust of the company.

MEDICAL PROFESSIONALS' CONCERNS

Doctors expressed outrage over the US "spying" tech giant being given access to NHS patient records. The British Medical Association and other professional bodies raised concerns about patient confidentiality and data security.

DATA ACCESS SCOPE

The NHS health records that Palantir has access to can include:
- Patient's name, age, address
- Health conditions, treatments and medicines
- Allergies, tests, scans, X-ray results
- Whether a patient smokes or drinks
- Hospital admission and discharge information

However, any data that may make patients personally identifiable are replaced with a pseudonym or aggregated before they're shared with Palantir, according to NHS England.

LSE MEDIA ANALYSIS

The London School of Economics published analysis titled "The Palantir-NHS partnership: examining big tech's infrastructural power in healthcare," examining how Palantir's role in the NHS demonstrates big tech's growing infrastructural power in public services.

HOW PALANTIR INFILTRATED THE STATE

Prospect Magazine published an investigation titled "How Palantir infiltrated the state," documenting the company's strategy for embedding itself in UK government institutions, starting with emergency COVID contracts and expanding to long-term data platform agreements.

ONGOING DEBATE

The Palantir-NHS partnership continues to generate debate about:
- The appropriate role of private tech companies in public healthcare
- Data privacy and patient consent in the digital age
- The risks of vendor lock-in with controversial companies
- Transparency and accountability in government contracting
